HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuhito Kojima Selected Research

lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)

1/2014Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuhito Kojima Research Topics

Disease

20Thrombosis (Thrombus)
01/2022 - 04/2002
10Hemorrhage
01/2023 - 08/2002
9Venous Thrombosis (Deep-Vein Thrombosis)
06/2018 - 02/2006
8Thrombophilia
02/2022 - 07/2014
6Leukemia
01/2014 - 03/2002
5Hemophilia A (Haemophilia)
02/2021 - 08/2006
5Inflammation (Inflammations)
10/2019 - 05/2005
4Hemophilia B (Haemophilia B)
01/2022 - 07/2015
4Neoplasms (Cancer)
01/2014 - 05/2004
4Neuroblastoma
06/2012 - 09/2007
3Venous Thromboembolism
06/2019 - 04/2002
3Vascular System Injuries
04/2018 - 04/2004
3Pneumonia (Pneumonitis)
02/2016 - 08/2012
3Colonic Neoplasms (Colon Cancer)
10/2015 - 05/2004
2Disseminated Intravascular Coagulation
01/2023 - 10/2006
2Protein S Deficiency (Deficiency, Protein S)
02/2022 - 07/2004
2Fibrosis (Cirrhosis)
10/2019 - 02/2004
2Hypoxia (Hypoxemia)
10/2015 - 05/2004
2Infections
02/2013 - 08/2012
2Carcinogenesis
08/2012 - 09/2007
2Breast Neoplasms (Breast Cancer)
06/2012 - 11/2009
2Infarction (Infarctions)
05/2011 - 02/2004
2Myocardial Infarction
05/2011 - 02/2004
2Obesity
05/2005 - 12/2002
1Aortic Diseases
01/2023
1Type 3 von Willebrand Disease
01/2022
1hereditary Thrombophilia
09/2021
1Inherited Blood Coagulation Disorders
06/2021
1Confusion (Bewilderment)
06/2021
1Splenomegaly
02/2021
1Joint Diseases (Joint Disease)
01/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2019
1Pulmonary Embolism
06/2018
1Disease Susceptibility (Diathesis)
03/2016
1Lung Diseases (Lung Disease)
02/2016
1Bacterial Pneumonia
11/2015
1Prostatic Neoplasms (Prostate Cancer)
10/2015
1Autoimmune Diseases (Autoimmune Disease)
08/2014
1Necrosis
07/2013

Drug/Important Bio-Agent (IBA)

16AntithrombinsIBA
09/2021 - 04/2002
11Proteins (Proteins, Gene)FDA Link
03/2016 - 12/2003
10Syndecan-4IBA
10/2019 - 05/2002
9Prothrombin (Factor II)IBA
06/2018 - 06/2012
8Protein SIBA
02/2022 - 10/2007
8Messenger RNA (mRNA)IBA
01/2022 - 02/2004
6Protein CIBA
09/2021 - 08/2002
5AnticoagulantsIBA
09/2021 - 01/2009
5Factor VIII (Coagulation Factor VIII)IBA
01/2020 - 06/2006
4Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2022 - 07/2015
4von Willebrand FactorIBA
01/2022 - 04/2004
4EnzymesIBA
10/2015 - 12/2003
4CytokinesIBA
07/2013 - 02/2004
4Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2012 - 03/2002
4Plasminogen Activator Inhibitor 1IBA
05/2005 - 11/2002
4Plasminogen Activators (Plasminogen Activator)IBA
05/2005 - 11/2002
3LigandsIBA
02/2013 - 03/2002
3LipopolysaccharidesIBA
08/2012 - 04/2002
3Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
06/2012 - 03/2002
2FibrinIBA
01/2023 - 08/2002
2Dacarbazine (DIC)FDA LinkGeneric
01/2023 - 10/2006
2Blood Coagulation Factors (Coagulation Factor)IBA
06/2021 - 03/2016
2Arginine (L-Arginine)FDA Link
06/2018 - 06/2012
2Transcription Factors (Transcription Factor)IBA
10/2015 - 01/2014
2ThrombomodulinIBA
06/2015 - 08/2002
2ThrombinFDA Link
07/2014 - 02/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 05/2004
2Daunorubicin (Cerubidine)FDA LinkGeneric
01/2014 - 11/2009
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
07/2013 - 05/2011
2Ribavirin (Virazole)FDA LinkGeneric
02/2013 - 01/2013
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
11/2011 - 09/2007
2Factor V (Coagulation Factor V)IBA
04/2010 - 11/2009
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2009 - 08/2002
2sphingosine kinaseIBA
09/2007 - 12/2003
1Tranexamic Acid (AMCA)FDA Link
01/2023
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2023
1Glycoproteins (Glycoprotein)IBA
01/2022
1DisulfidesIBA
01/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1protein S TokushimaIBA
09/2021
1Indicators and Reagents (Reagents)IBA
02/2021
1Hemoglobins (Hemoglobin)IBA
02/2021
1ErythropoietinFDA Link
02/2021
1Chromogenic CompoundsIBA
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2019
1CollagenIBA
10/2019
1emicizumabIBA
10/2019
1Combined Oral ContraceptivesIBA
09/2016
1Biomarkers (Surrogate Marker)IBA
11/2015
1Glucose (Dextrose)FDA LinkGeneric
10/2015
1Deubiquitinating EnzymesIBA
10/2015
1Acid CeramidaseIBA
10/2015
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2015
1UbiquitinIBA
10/2015
1AndrogensIBA
10/2015
1Fibrinogen (Factor I)FDA Link
10/2014
1Heparin (Liquaemin)FDA LinkGeneric
02/2014
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2014
1DNA Ligase ATPIBA
01/2014

Therapy/Procedure

4Therapeutics
01/2023 - 06/2006
1Perioperative Period
10/2019